N-methyl Topiramate Impurity is a structurally related degradation byproduct of Topiramate, characterized by an N-methyl substitution on the sulfonamide nitrogen of the parent compound. This modification introduces a methylated sulfonamide group, retaining the core cyclopropane-fused 1,3-thiazole ring and ester functionality. The compound exhibits a branched aliphatic side chain with a terminal methyl group, differing from Topiramateβs linear configuration. Its molecular architecture facilitates specific interactions in chromatographic analysis, serving as an HPLC reference standard for quantifying N-methylated impurities in Topiramate drug substances.
On RequestCC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)NC)C
InChI=1S/C13H23NO8S/c1-11(2)19-8-6-17-13(7-18-23(15,16)14-5)10(9(8)20-11)21-12(3,4)22-13/h8-10,14H,6-7H2,1-5H3/t8-,9-,10+,13+/m1/s1
LDHJVCCWWXVXBN-DNJQJEMRSA-N